...ORLANDO Fla. June 13 2012 /- Union Equity Inc. (O...Each year 10.9 million people worldwide are diagnosed with cancer and...Union Equity's subsidiary Natural Product Laboratories announces today... As a mother who had to watch her daughter go through cancer treatment...

Each year, 10.9 million people worldwide are diagnosed with cancer and this incidence is rising. This increase reflects the world's growing population and the fact that people are living longer, according to the New Zealand Dermatological Society (dermnetnz.org). Chemotherapy and radiation treatment are in many cases crucial components to cancer management, a treatment that itself does not come without side effects, as doctors and patients alike will see an increasing incidence of, among other unwanted effects, cancer treatment related skin toxicity. Chemotherapy and radiation may cause skin irritations, such as redness, peeling, itching and dryness. The skin may look as if it is sunburned or tanned, and acne issues may present themselves.

Union Equity's subsidiary Natural Product Laboratories announces today that it is beginning its initial product distribution of three different versions of its Allevium product: Allevium Intense Repair Creme, Allevium Daily Moisture Creme and Allevium Solor Protection SPF 30. The Allevium line's target market is anyone who is looking to soothe the burns, breakouts and skin irritation suffered from chemotherapy and radiation therapy.

"As a mother who had to watch her daughter go through cancer treatments that ravaged her skin, I am proud to offer her and others a solution that will relieve them of their skin irritations," stated Pat Landers, Assistant Director of Operations for Natural Product Laboratories LLC. "I know the pain families feel standing by helplessly, watching their loved ones suffer. Our chemist and micro-biologist have developed a formulation that combines natural vitamins and plant extracts, along with other reparative ingredients, that soothe and nurture damaged skin from any cause, but in particular whose skin damage is a result of cancer related skin toxicity."

* The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and this product is not intended to diagnose, treat, cure, or prevent any disease.

About Natural Product Laboratories LLC:The Natural Product Laboratories LLC (NPL) laboratory and production facility is located in Melbourne, Florida and is FDA regulated and certified as well as Green Seal approved to produce the highest quality skin-care, personal care, hair, pet, baby and sunscreen products. The Company specializes in formulizations of new product lines as well as reverse engineering existing products. The staff includes a licensed chemist and certified microbiologist, with over 25 years' combined experience. NPL's skilled production team and broad range of equipment allows them to accommodate almost any size order. Packaging capabilities include a wide range of sizes for both professional and retail use.

Safe Harbor Act:This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...

(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...

(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...

(Date:4/3/2017)... April 3, 2017 Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...